Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Shimada

Showing results (161-170 of 365) with videos related to

Pageof 37
Sort By:
Surgery|July 12, 2002
Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinomaHideaki Shimada, Yoshihiro Nabeya, Shin-Ichi Okazumi, et al.
Surgery|May 30, 2003
Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinomaHideaki Shimada, Yoshihiro Nabeya, Shin-ichi Okazumi, et al.
American Journal of Surgery|March 21, 2007
Surgical outcome after the clearance of abdominal metastatic lymph nodes in 138 patients with thoracic esophageal carcinomaHideaki Shimada, Shin-ichi Okazumi, Hisahiro Matsubara, et al.
Hepato-Gastroenterology|April 11, 2007
Surgical outcome of patients with thoracic esophageal cancer positive for cervical lymph nodesHideaki Shimada, Tooru Shiratori, Shin-ichi Okazumi, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 30, 2020
Combination of a p53-activating CP-31398 and an MDM2 or a FAK inhibitor produces growth suppressive effects in mesothelioma with wild-type p53 genotypeBoya Zhong, Masato Shingyoji, Michiko Hanazono, et al.
Journal of the American College of Surgeons|April 15, 2003
Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinomaHideaki Shimada, Yoshihiro Nabeya, Shin-ichi Okazumi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresisTakeshi Tomonaga, Kazuyuki Matsushita, Seiko Yamaguchi, et al.
World Journal of Surgery|July 28, 2006
Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissectionHideaki Shimada, Shin-ichi Okazumi, Hisahiro Matsubara, et al.
Oncology Reports|February 13, 2003
Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancerHideaki Shimada, Yoshihiro Nabeya, Shin-ichi Okazumi, et al.
Journal of the American College of Surgeons|April 28, 2004
Thrombocytosis associated with poor prognosis in patients with esophageal carcinomaHideaki Shimada, Gaku Oohira, Shin-ichi Okazumi, et al.
Pageof 37

Showing results (161-170 of 365) with videos related to

Sort By:
Pageof 37
Surgery|July 12, 2002
Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinomaHideaki Shimada, Yoshihiro Nabeya, Shin-Ichi Okazumi, et al.
Surgery|May 30, 2003
Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinomaHideaki Shimada, Yoshihiro Nabeya, Shin-ichi Okazumi, et al.
American Journal of Surgery|March 21, 2007
Surgical outcome after the clearance of abdominal metastatic lymph nodes in 138 patients with thoracic esophageal carcinomaHideaki Shimada, Shin-ichi Okazumi, Hisahiro Matsubara, et al.
Hepato-Gastroenterology|April 11, 2007
Surgical outcome of patients with thoracic esophageal cancer positive for cervical lymph nodesHideaki Shimada, Tooru Shiratori, Shin-ichi Okazumi, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 30, 2020
Combination of a p53-activating CP-31398 and an MDM2 or a FAK inhibitor produces growth suppressive effects in mesothelioma with wild-type p53 genotypeBoya Zhong, Masato Shingyoji, Michiko Hanazono, et al.
Journal of the American College of Surgeons|April 15, 2003
Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinomaHideaki Shimada, Yoshihiro Nabeya, Shin-ichi Okazumi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresisTakeshi Tomonaga, Kazuyuki Matsushita, Seiko Yamaguchi, et al.
World Journal of Surgery|July 28, 2006
Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissectionHideaki Shimada, Shin-ichi Okazumi, Hisahiro Matsubara, et al.
Oncology Reports|February 13, 2003
Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancerHideaki Shimada, Yoshihiro Nabeya, Shin-ichi Okazumi, et al.
Journal of the American College of Surgeons|April 28, 2004
Thrombocytosis associated with poor prognosis in patients with esophageal carcinomaHideaki Shimada, Gaku Oohira, Shin-ichi Okazumi, et al.
Pageof 37